• Issue

    HemaSphere: Volume 9, Issue 6

    June 2025
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 03 June 2025

LETTER

Open Access

Fetal-hemoglobin-expressing red blood cells (“F cells”) consist of three distinct types as revealed by single-cell transcriptomic analysis of circulating reticulocytes

Helen Rooks,  Cecilia Ng,  Spyros Oikonomopoulos,  Sara El Hoss,  Charles Turner,  Kar Lok Kong,  Syed Mian,  Yvonne Daniel,  Oyesola O. Ojewunmi,  John Brewin,  David Rees,  Ghulam J. Mufti,  Jiannis Ragoussis,  John Strouboulis,  Stephan Menzel, 
  • First Published: 25 June 2025

REVIEW ARTICLE

Open Access

NK-type large granular lymphocyte leukemia comes of age

Gianpietro Semenzato,  Antonella Teramo,  Gregorio Barilà,  Giulia Calabretto,  Elisa Rampazzo,  Elena Buson,  Renato Zambello, 
  • First Published: 25 June 2025

HemaTopics

Open Access

Examining the secret life of the spleen in sickle cell disease

Adama Ladu,  Stephen P. Hibbs, 
  • First Published: 17 June 2025

ARTICLE

Open Access

Comparable outcomes for pediatric acute lymphoblastic leukemia patients receiving conditioning with total body irradiation or chemotherapy: A nationwide, Korean registry-based study

Kyung Taek Hong,  Jung Yoon Choi,  Hyery Kim,  Ho Joon Im,  Seung Min Hahn,  Chuhl Joo Lyu,  Hee Young Ju,  Keon Hee Yoo,  Eu Jeen Yang,  Sung-Soo Yoon,  Hyeon Jin Park,  Hyoung Soo Choi,  Hee Won Chueh,  Deok-Hwan Yang,  Joon Ho Moon,  Jae Min Lee,  Jung-Hee Lee,  Jeong-A Kim,  Jong-Ho Won,  Hyoung Jin Kang, 
  • First Published: 17 June 2025
Open Access

Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma

Patrick Born,  David Fandrei,  Song Yau Wang,  Carmen Perez-Fernandez,  Luise Fischer,  Jule Ussmann,  Enrica Bach,  Sandra Hoffmann,  Klaus H. Metzeler,  Marco Herling,  Carmen Herling,  Madlen Jentzsch,  Andreas Boldt,  Sabine Seiffert,  Ronny Baber,  Heike Weidner,  Georg-Nikolaus Franke,  Timm Denecke,  Osama Sabri,  Uwe Platzbecker,  Vladan Vucinic,  Hans Jonas Meyer,  Lars Kurch,  Maximilian Merz, 
  • First Published: 15 June 2025
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma

Open Access

Expanding the phenotypic and genetic landscape of congenital neutropenia through whole-exome and genome sequencing

Séverine Marti,  Philippe Pellet,  Blandine Beaupain,  Léa Durix,  Julien Buratti,  Yves Réguerre,  Nathalie Aladjidi,  Saba Azarnoush,  Severine Clauin,  Wahid Abou Chahla,  Gilles Blaison,  Jeremy Bertand,  Damien Bodet,  Benoit Brethon,  Jessica Chane-Teng,  Manon Delafoy,  Chrystelle Dupraz,  Virginie Gandemer,  Philippe Denizeau,  Alice Goldenberg,  Pierre Hirsch,  Anaïs l'Haridon,  Aude Marie-Cardine,  Gabriella Vera,  Brigitte Nelken,  Laure Nizery,  Marie Nolla,  Marlène Pasquet,  Jérémie Rosain,  Louis Terriou,  Isabelle Plo,  Jean Donadieu,  Christine Bellanné-Chantelot, 
  • First Published: 11 June 2025
Expanding the phenotypic and genetic landscape of congenital neutropenia through whole-exome and genome sequencing

LETTER

Open Access

Development of myeloid neoplasia associated with prolonged immune cell-associated hematotoxicity after CAR T-cell treatment of B-cell lymphoma: Should we surveille for pre-existing myeloid mutations?

Mattias Carlsten,  Elisa Linnea Lindfors Rossi,  Martin Jädersten,  Bianca Tesi,  Sulaf Abd Own,  Brigitta Sander,  Stefan Deneberg,  Anne Ivinskiy,  Kristina Sonnevi,  Hanna Sjölund,  Gunilla Enblad,  Björn Wahlin,  Stephan Mielke, 
  • First Published: 05 June 2025
Open Access

Efficacy of erythroid-stimulating agent and luspatercept in VEXAS syndrome: A multicenter retrospective study by the FRENVEX group

Maël Heiblig,  Vincent Jachiet,  Jérôme Hadjadj,  Lin Pierre Zhao,  Thibault Comont,  Hervé Lobbes,  Valentin Lacombe,  Anne Blandine Boutin,  Joris Galland,  Benjamin Terrier,  Sophie Georgin-Lavialle,  Pierre Fenaux,  Arsène Mekinian,  the FRENVEX Group , 
  • First Published: 03 June 2025

REVIEW ARTICLE

Open Access

New horizons in the pharmacological management of venous thromboembolism

Andreas Verstraete,  Quentin Van Thillo,  Thomas Vanassche,  Peter Verhamme, 
  • First Published: 03 June 2025